Search Results - Vriend, Tessa

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study

    Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study by van Baar, Annieke C.G., Meiring, Suzanne, Smeele, Paul, Vriend, Tessa, Holleman, Frits, Barlag, Marjon, Mostafavi, Nahid, Tijssen, Jan G.P., Soeters, Maarten R., Nieuwdorp, Max, Bergman, Jacques J.G. H.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Sa1962 DUODENAL MUCOSAL RESURFACING (DMR) COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT WHILE MAINTAINING GLYCAEMIC CONTROL AND IMPROVING OVERALL METABOLIC HEALTH IN TYPE 2 DIABETES

    Sa1962 DUODENAL MUCOSAL RESURFACING (DMR) COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT WHILE MAINTAINING GLYCAEMIC CONTROL AND IMPROVING OVERALL METABOLIC H... by van Baar, Annieke, Smeele, Paul, Vriend, Tessa M., Holleman, Frits, Tijssen, Jan, Nieuwdorp, Max, Bergman, Jacques

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Sa1939 DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCEMIC CONTROL AND OVERALL METABOLIC HEALTH

    Sa1939 DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCEMIC CONTROL AND OVERALL METABOLIC H... by Meiring, Suzanne, van Baar, Annieke, Smeele, Paul, Vriend, Tessa, Holleman, Frits, Barlag, Marjon, Mostafavi, Nahid, Tijssen, J.G.P., Soeters, M.R., Nieuwdorp, Max, Bergman, Jacques

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: